Full Text View
Tabular View
No Study Results Posted
Related Studies
Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy (IMMC-38)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2008 by Immunicon.
Recruitment status was  Active, not recruiting
Study NCT00133900   Information provided by Immunicon

First Received on August 22, 2005.   Last Updated on July 27, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hormone Refractory Prostate Cancer
Prostate Cancer
Additional conditions recognized in this trial
Neoplastic Cells, Circulating
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasm Metastasis
Neoplasms
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
Phlebotomy
Additional drug interventions recognized in this trial
Hormones
More general drug interventions related to this trial
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Immunicon


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services